Search Results - "Aljohani, Abrar I"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer by Aljohani, Abrar I., Joseph, Chitra, Kurozumi, Sasagu, Mohammed, Omar J., Miligy, Islam M., Green, Andrew R., Rakha, Emad A.

    Published in Breast cancer research and treatment (01-06-2020)
    “…Background Breast cancer (BC) is a disease with variable morphology, clinical behaviour and response to therapy. Identifying factors associated with the…”
    Get full text
    Journal Article
  2. 2

    The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer by Aljohani, Abrar I., Toss, Michael S., Kurozumi, Sasagu, Joseph, Chitra, Aleskandarany, Mohammed A., Miligy, Islam M., Ansari, Rokaya El, Mongan, Nigel P., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.

    Published in Breast cancer research and treatment (01-01-2020)
    “…Background Lymphovascular invasion (LVI) is a prerequisite step in breast cancer (BC) metastasis. We have previously identified wild-type isocitrate…”
    Get full text
    Journal Article
  3. 3

    The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development by Aljohani, Abrar I., Toss, Michael S., Green, Andrew R., Rakha, Emad A.

    Published in Breast cancer research and treatment (01-04-2023)
    “…Background Lymphovascular invasion (LVI) is regulated through complex molecular mechanisms. Cyclin B1 ( CCNB1 ) was previously determined as being associated…”
    Get full text
    Journal Article
  4. 4

    Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer by Elsharawy, Khloud A., Althobiti, Maryam, Mohammed, Omar J., Aljohani, Abrar I., Toss, Michael S., Green, Andrew R., Rakha, Emad A.

    Published in Breast cancer research and treatment (01-02-2021)
    “…Purpose Nucleolar protein 10 (NOP10) is required for ribosome biogenesis and telomere maintenance and plays a key role in carcinogenesis. This study aims to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Myxovirus resistance 1 by Kurozumi, Sasagu, Green, Andrew R, Rakha, Emad A, Joseph, Chitra, Aljohani, Abrar I, Miligy, Islam M, Mohammed, Omar J

    Published in Breast cancer research and treatment (01-06-2020)
    “…Background Breast cancer (BC) is a disease with variable morphology, clinical behaviour and response to therapy. Identifying factors associated with the…”
    Get full text
    Journal Article
  7. 7

    Upregulation of Cyclin B2 ( CCNB2 ) in breast cancer contributes to the development of lymphovascular invasion by Aljohani, Abrar I, Toss, Michael S, El-Sharawy, Khloud A, Mirza, Sameer, Ball, Graham R, Green, Andrew R, Rakha, Emad A

    Published in American journal of cancer research (01-01-2022)
    “…Lymphovascular invasion (LVI) is a key step in breast cancer (BC) metastasis. Targeting the molecular drivers of LVI can improve BC patients' management…”
    Get full text
    Journal Article
  8. 8

    The expression of high mobility group protein 3 ( HMGB3 ) in breast cancer with emphasis on its role in lymphovascular invasion by Aljohani, Abrar I, Alsaeed, Sami A, Toss, Michael S, Raafat, Sara A, Green, Andrew R, Rakha, Emad A

    Published in American journal of cancer research (01-01-2023)
    “…Lymphovascular invasion (LVI) is a common phenomenon in breast cancer (BC), and it is correlated to poor outcome. However, the biomarkers that influence the…”
    Get full text
    Journal Article